Literature DB >> 11692293

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

J R Perfect1, G M Cox, J Y Lee, C A Kauffman, L de Repentigny, S W Chapman, V A Morrison, P Pappas, J W Hiemenz, D A Stevens.   

Abstract

The term "aspergillosis" comprises several categories of infection: invasive aspergillosis; chronic necrotizing aspergillosis; aspergilloma, or fungus ball; and allergic bronchopulmonary aspergillosis. In 24 medical centers, we examined the impact of a culture positive for Aspergillus species on the diagnosis, risk factors, management, and outcome associated with these diseases. Most Aspergillus culture isolates from nonsterile body sites do not represent disease. However, for high-risk patients, such as allogeneic bone marrow transplant recipients (60%), persons with hematologic cancer (50%), and those with signs of neutropenia (60%) or malnutrition (30%), a positive culture result is associated with invasive disease. When such risk factors as human immunodeficiency virus infection (20%), solid-organ transplantation (20%), corticosteroid use (20%), or an underlying pulmonary disease (10%) are associated with a positive culture result, clinical judgment and better diagnostic tests are necessary. The management of invasive aspergillosis remains suboptimal: only 38% of patients are alive 3 months after diagnosis. Chronic necrotizing aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis have variable management strategies and better short-term outcomes.

Entities:  

Mesh:

Year:  2001        PMID: 11692293     DOI: 10.1086/323900

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  93 in total

Review 1.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 2.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

3.  Pathogen identification by nuclear imaging--almost there?

Authors:  Samir G Agrawal; Stephen J Mather
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07       Impact factor: 9.236

4.  Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production.

Authors:  Robert A Cramer; Michael P Gamcsik; Rhea M Brooking; Laura K Najvar; William R Kirkpatrick; Thomas F Patterson; Carl J Balibar; John R Graybill; John R Perfect; Soman N Abraham; William J Steinbach
Journal:  Eukaryot Cell       Date:  2006-06

5.  Aspergillosis of biliary tract after liver transplantation: a case report.

Authors:  Chen Yuchong; Zhu Dingheng; Yuan Zhizhong; Yu Hongyu; He Jing; Chen Jianghan
Journal:  Mycopathologia       Date:  2010-03-24       Impact factor: 2.574

6.  Invasive aspergillosis in the ICU: an emerging disease.

Authors:  Wouter Meersseman; Eric Van Wijngaerden
Journal:  Intensive Care Med       Date:  2007-07-24       Impact factor: 17.440

Review 7.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Aspergillus osteomyelitis of the lumbar spine complicated with orbital apex syndrome: A potential role of the Batson's plexus in disease propagation.

Authors:  Jose F Camargo; Vimon Seriburi; Michael Tenner; Marc Y El Khoury
Journal:  Med Mycol Case Rep       Date:  2012-03-15

9.  Sternal osteomyelitis caused by Aspergillus fumigatus following cardiac surgery: Case and review.

Authors:  Kingsley A Asare; Maximillian Jahng; Jennifer L Pincus; Larry Massie; Samuel A Lee
Journal:  Med Mycol Case Rep       Date:  2012-12-07

Review 10.  [Update: invasive fungal infections: Diagnosis and treatment in surgical intensive care medicine].

Authors:  C Lichtenstern; S Swoboda; M Hirschburger; E Domann; T Hoppe-Tichy; M Winkler; C Lass-Flörl; M A Weigand
Journal:  Anaesthesist       Date:  2010-01       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.